- The widespread availability of SARS-CoV-2 tests is limited. In the USA, for example, an adequate, state-funded testing facility for all suspected cases has only been available since 11.3.2020 [6]. In Germany as well, there were occasional bottlenecks which contribute to an overestimation of the CFR.